Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 2
2004 6
2005 6
2006 2
2007 2
2008 4
2009 6
2010 1
2011 4
2012 3
2013 3
2014 5
2015 4
2016 9
2017 5
2018 6
2019 6
2020 9
2021 8
2022 11
2023 10
2024 7
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

107 results

Results by year

Filters applied: . Clear all
Page 1
Clinical consensus guideline on the management of phaeochromocytoma and paraganglioma in patients harbouring germline SDHD pathogenic variants.
Taïeb D, Wanna GB, Ahmad M, Lussey-Lepoutre C, Perrier ND, Nölting S, Amar L, Timmers HJLM, Schwam ZG, Estrera AL, Lim M, Pollom EL, Vitzthum L, Bourdeau I, Casey RT, Castinetti F, Clifton-Bligh R, Corssmit EPM, de Krijger RR, Del Rivero J, Eisenhofer G, Ghayee HK, Gimenez-Roqueplo AP, Grossman A, Imperiale A, Jansen JC, Jha A, Kerstens MN, Kunst HPM, Liu JK, Maher ER, Marchioni D, Mercado-Asis LB, Mete O, Naruse M, Nilubol N, Pandit-Taskar N, Sebag F, Tanabe A, Widimsky J, Meuter L, Lenders JWM, Pacak K. Taïeb D, et al. Among authors: bourdeau i. Lancet Diabetes Endocrinol. 2023 May;11(5):345-361. doi: 10.1016/S2213-8587(23)00038-4. Epub 2023 Mar 31. Lancet Diabetes Endocrinol. 2023. PMID: 37011647 Free PMC article. Review.
Management of phaeochromocytoma and paraganglioma in patients with germline SDHB pathogenic variants: an international expert Consensus statement.
Taïeb D, Nölting S, Perrier ND, Fassnacht M, Carrasquillo JA, Grossman AB, Clifton-Bligh R, Wanna GB, Schwam ZG, Amar L, Bourdeau I, Casey RT, Crona J, Deal CL, Del Rivero J, Duh QY, Eisenhofer G, Fojo T, Ghayee HK, Gimenez-Roqueplo AP, Gill AJ, Hicks R, Imperiale A, Jha A, Kerstens MN, de Krijger RR, Lacroix A, Lazurova I, Lin FI, Lussey-Lepoutre C, Maher ER, Mete O, Naruse M, Nilubol N, Robledo M, Sebag F, Shah NS, Tanabe A, Thompson GB, Timmers HJLM, Widimsky J, Young WJ Jr, Meuter L, Lenders JWM, Pacak K. Taïeb D, et al. Among authors: bourdeau i. Nat Rev Endocrinol. 2024 Mar;20(3):168-184. doi: 10.1038/s41574-023-00926-0. Epub 2023 Dec 14. Nat Rev Endocrinol. 2024. PMID: 38097671 Review.
Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study.
Terzolo M, Fassnacht M, Perotti P, Libé R, Kastelan D, Lacroix A, Arlt W, Haak HR, Loli P, Decoudier B, Lasolle H, Quinkler M, Haissaguerre M, Chabre O, Caron P, Stigliano A, Giordano R, Zatelli MC, Bancos I, Fragoso MCBV, Canu L, Luconi M, Puglisi S, Basile V, Reimondo G, Kroiss M, Megerle F, Hahner S, Kimpel O, Dusek T, Nölting S, Bourdeau I, Chortis V, Ettaieb MH, Cosentini D, Grisanti S, Baudin E, Berchialla P, Bovis F, Sormani MP, Bruzzi P, Beuschlein F, Bertherat J, Berruti A. Terzolo M, et al. Among authors: bourdeau i. Lancet Diabetes Endocrinol. 2023 Oct;11(10):720-730. doi: 10.1016/S2213-8587(23)00193-6. Epub 2023 Aug 21. Lancet Diabetes Endocrinol. 2023. PMID: 37619579 Free PMC article. Clinical Trial.
Aberrant hormone receptors regulate a wide spectrum of endocrine tumors.
Lacroix A, Bourdeau I, Chasseloup F, Kamenický P, Lopez AG, Louiset E, Lefebvre H. Lacroix A, et al. Among authors: bourdeau i. Lancet Diabetes Endocrinol. 2024 Nov;12(11):837-855. doi: 10.1016/S2213-8587(24)00200-6. Epub 2024 Sep 23. Lancet Diabetes Endocrinol. 2024. PMID: 39326429 Review.
Adrenocortical hyperplasia: A multifaceted disease.
Bourdeau I, Parisien-La Salle S, Lacroix A. Bourdeau I, et al. Best Pract Res Clin Endocrinol Metab. 2020 May;34(3):101386. doi: 10.1016/j.beem.2020.101386. Epub 2020 Feb 4. Best Pract Res Clin Endocrinol Metab. 2020. PMID: 32115357 Review.
Diagnosis and management of secondary adrenal crisis.
Martel-Duguech L, Poirier J, Bourdeau I, Lacroix A. Martel-Duguech L, et al. Among authors: bourdeau i. Rev Endocr Metab Disord. 2024 Jun;25(3):619-637. doi: 10.1007/s11154-024-09877-x. Epub 2024 Feb 27. Rev Endocr Metab Disord. 2024. PMID: 38411891 Review.
Endogenous Cushing's syndrome during pregnancy.
Younes N, St-Jean M, Bourdeau I, Lacroix A. Younes N, et al. Among authors: bourdeau i. Rev Endocr Metab Disord. 2023 Feb;24(1):23-38. doi: 10.1007/s11154-022-09731-y. Epub 2022 Jun 7. Rev Endocr Metab Disord. 2023. PMID: 35670990 Review.
Latent Adrenal Insufficiency: From Concept to Diagnosis.
Younes N, Bourdeau I, Lacroix A. Younes N, et al. Among authors: bourdeau i. Front Endocrinol (Lausanne). 2021 Aug 27;12:720769. doi: 10.3389/fendo.2021.720769. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34512551 Free PMC article. Review.
Primary bilateral macronodular adrenal hyperplasia.
De Venanzi A, Alencar GA, Bourdeau I, Fragoso MC, Lacroix A. De Venanzi A, et al. Among authors: bourdeau i. Curr Opin Endocrinol Diabetes Obes. 2014 Jun;21(3):177-84. doi: 10.1097/MED.0000000000000061. Curr Opin Endocrinol Diabetes Obes. 2014. PMID: 24739311 Review.
107 results